Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 1.88 USD -4.08% Market Closed
Market Cap: 391.5m USD
Have any thoughts about
Sangamo Therapeutics Inc?
Write Note

Wall Street
Price Targets

SGMO Price Targets Summary
Sangamo Therapeutics Inc

Wall Street analysts forecast SGMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGMO is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.

Lowest
Price Target
2.02 USD
7% Upside
Average
Price Target
6.32 USD
236% Upside
Highest
Price Target
10.5 USD
459% Upside
Sangamo Therapeutics Inc Competitors:
Price Targets
APLT
Applied Therapeutics Inc
36% Upside
SANA
Sana Biotechnology Inc
320% Upside
ALRN
Aileron Therapeutics Inc
437% Upside
206650
EuBiologics Co Ltd
12% Upside
LCTX
Lineage Cell Therapeutics Inc
684% Upside
STTK
Shattuck Labs Inc
103% Upside
AURA
Aura Biosciences Inc
156% Upside
TWST
Twist Bioscience Corp
28% Upside

Revenue
Forecast

Revenue Estimate
Sangamo Therapeutics Inc

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 3 years is -15%.

21%
Past Growth
-15%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGMO's stock price target?
Price Target
6.32 USD

According to Wall Street analysts, the average 1-year price target for SGMO is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.

What is Sangamo Therapeutics Inc's Revenue forecast?
Projected CAGR
-15%

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 3 years is -15%.

Back to Top